Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Urology

• Publication date

  2004-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.JU.0000132126.85812.7DPMID 15201737
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic factors of response or failure of treatment in patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie

  2005cited by this paper
• Long-Term Results of Nephron Sparing Surgery for Localized Renal Cell Carcinoma

  2004cited by this paper
• Cancer Statistics, 2003

  2003cited by this paper
• A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.

  2003cited by this paper
• Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors.

  2002cited by this paper
• Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie.

  2002cited by this paper
• The changing natural history of renal cell carcinoma.

  2001cited by this paper
• Contemporary approach to the classification of renal epithelial tumors.

  2000cited by this paper
• Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup.

  2000cited by this paper
• Contemporary approach to the classification of renal epithelial tumors.

  2000cited by this paper
• Matched comparison of radical nephrectomy vs nephron-sparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney.

  2000cited by this paper
• Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.

  2000cited by this paper
• Renal cell carcinoma: management of advanced disease.

  1999cited by this paper
• Follow‐up guidelines for nonmetastatic renal cell carcinoma based on the occurrence of metastases after radical nephrectomy

  1999cited by this paper
• Stage specific guidelines for surveillance after radical nephrectomy for local renal cell carcinoma.

  1998cited by this paper
• Resection of metastatic renal cell carcinoma.

  1998cited by this paper
• Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.

  1997cited by this paper
• The Heidelberg classification of renal cell tumours

  1997cited by this paper
• Renal-cell carcinoma.

  1996cited by this paper
• Therapy of locally recurrent renal cell carcinoma after nephrectomy.

  1996cited by this paper
• A new protocol for the followup of renal cell carcinoma based on pathological stage.

  1995cited by this paper
• Follow-up after partial or total nephrectomy for renal cell carcinoma.

  1994cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Prognostic impact of non-clear cell histology on recurrence and cancer-free survival in renal cell carcinoma: a time-to-event analysis

  2025cites this paper
• Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort

  2024cites this paper
• Renal cancer: signaling pathways and advances in targeted therapies

  2024cites this paper
• Endobronchial metastasis secondary to renal clear cell carcinoma: A case report

  2024cites this paper
• Current Treatment Options for Renal Cell Carcinoma: Focus on Cell-Based Immunotherapy

  2024cites this paper
• Clear Cell Renal Carcinoma Presents as a Solitary Pulmonary Nodule Fifteen Years After Nephrectomy

  2023cites this paper
• Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United States.

  2023cites this paper
• ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma: 2021 Update.

  2022cites this paper
• Clinical Outcomes of Robotic Assisted Partial Nephrectomy for Pathologic T3a Renal Masses with Venous Tumor Thrombus.

  2021cites this paper
• Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Carcinoma

  2021influential citation
• Imaging and its Impact on Defining the Oligometastatic State.

  2021cites this paper
• A Contemporary Review of Immune Checkpoint Inhibitors in Advanced Clear Cell Renal Cell Carcinoma

  2021cites this paper
• Recurrence Risk of Renal Cell Carcinoma Lingers Even Decades After Nephrectomy

  2021cites this paper
• Single-Cell Sequencing to Identify Six Heat Shock Protein (HSP) Genes-Mediated Progression Subtypes of Clear Cell Renal Cell Carcinoma

  2021cites this paper
• Adjuvant Therapy in Renal Cell Carcinoma: Current Status and Future Directions

  2021cites this paper
• A meta-analysis for comparison of partial nephrectomy vs. radical nephrectomy in patients with pT3a renal cell carcinoma

  2021cites this paper
• Patterns of surveillance intensity in kidney cancer

  2020cites this paper
• Ablation of Renal Cell Carcinoma

  2020cites this paper
• Understanding the role of salvage lymphadenectomy in node only recurrences after nephrectomy for renal cell carcinoma.

  2020cites this paper
• Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement

  2020cites this paper
• The Limited Usefulness of Ultrasound Surveillance after Radical and Partial Nephrectomy for Renal Cell Carcinoma.

  2020cites this paper
• Renal Cell Carcinoma Follow-Up - Is it Time to Abandon Ultrasound?

  2019cites this paper
• Impact of routine imaging in the diagnosis of recurrence for patients with localized and locally advanced renal tumor treated with nephrectomy

  2019cites this paper
• Nachsorge beim Nierenzellkarzinom im nicht fernmetastasierten Stadium

  2019cites this paper
• Postoperative Surveillance Protocols for Renal Cell Carcinoma

  2019cites this paper
• Outcomes of Nephron Sparing in a Specialist Cancer Hospital of a Developing Country

  2019cites this paper
• Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a useful predictor of survival

  2019influential citation
• Long-term Outcomes of Follow-up for Initially Localised Clear Cell Renal Cell Carcinoma: RECUR Database Analysis.

  2019cites this paper
• Editorial Comment.

  2019cites this paper
• Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer Variant

  2019influential citation
• Robotic Radical Nephrectomy and Thrombectomy for Left Renal Cell Carcinoma with Renal Vein Tumor Thrombus: Superior Mesenteric Artery as an Important Strategic Dividing Landmark

  2019cites this paper
• Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer

  2019influential citation
• Surgical Consideration in Renal Tumors

  2019cites this paper
• Nachsorge beim Nierenzellkarzinom im nicht fernmetastasierten Stadium

  2019cites this paper
• Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C.: results from a European multicenter database (R.E.C.U.R.)

  2019cites this paper
• FTO mRNA expression in the lower quartile is associated with bad prognosis in clear cell renal cell carcinoma based on TCGA data mining.

  2019cites this paper
• Kidney and Ureter Neoplasm

  2019cites this paper
• Is Chest Computed Tomography Always Necessary Following Nephrectomy for Renal Cell Carcinoma? A Pilot Study in Single Tertiary Institution

  2019cites this paper
• Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma.

  2019cites this paper
• Patterns of Relapse and Implications for Post-Nephrectomy Surveillance in Patients with High Risk Nonclear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 Trial

  2019cites this paper
• ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer.

  2019cites this paper
• Tumor Multicomponent Targeting Polymer-Lipid Hybrid Nanoparticles To Overcome Drug Resistance In Renal Cell Carcinoma

  2018cites this paper
• Ultrasound

  2018cites this paper
• Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma

  2018cites this paper
• Risk‐adjusted proposal for >60 months follow up after surgical treatment of organ‐confined renal cell carcinoma according to life expectancy

  2018cites this paper
• Utility of Pelvic CT for Surveillance of T2-T4 Renal Cell Carcinoma After Nephrectomy With Curative Intent.

  2018cites this paper
• miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma

  2018cites this paper
• Targeting Endoglin to Treat Metastatic Renal Cell Carcinoma: Lessons from Osler‐Weber‐Rendu Syndrome

  2018cites this paper
• Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma.

  2018cites this paper
• Unusual presentation of late recurrence renal malignancy

  2018cites this paper
• Re: A Prospective Risk-Stratified Follow-up Programme for Radically Treated Renal Cell Carcinoma Patients: Evaluation after Eight Years of Clinical Use

  2017cites this paper
• Angiogenic, inflammatory and immunologic markers in predicting response to sunitinib in metastatic renal cell carcinoma

  2017cites this paper
• Renal cell carcinoma with contralateral synchronous adrenal and lung metastasis: A rare case report

  2017cites this paper
• Stromal expression of Fer suppresses tumor progression in renal cell carcinoma and is a predictor of survival.

  2017cites this paper
• Findings and Impact of Early Imaging After Partial Nephrectomy

  2017cites this paper
• Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors

  2017cites this paper
• A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell Carcinoma

  2017cites this paper
• Capturing Renal Cell Carcinoma Recurrences When Asymptomatic Improves Patient Survival

  2017cites this paper
• Treatment of renal cell carcinoma: Current status and future directions

  2017cites this paper
• Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score Analysis

  2017cites this paper
• Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma

  2017cites this paper
• Klinische und pathologische Prognosefaktoren für das Langzeitüberleben von Patienten mit pT1 Nierenzellkarzinom

  2017cites this paper
• Imaging strategy and outcome following partial nephrectomy.

  2017cites this paper
• Patterns and Predictors of Recurrence after Partial Nephrectomy for Kidney Tumors

  2017cites this paper
• Renal Cell Carcinoma: Presentation and Management - A Single Centre Experience

  2017cites this paper
• Statin use and kidney cancer survival outcomes: A systematic review and meta-analysis.

  2017cites this paper
• Spotlight on nivolumab in the treatment of renal cell carcinoma: design, development, and place in therapy

  2017cites this paper
• Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients

  2016cites this paper
• Pathological Upstaging of Clinical T1 to Pathological T3a Renal Cell Carcinoma: A Multi-institutional Analysis of Short-term Outcomes.

  2016cites this paper
• Port-site metastasis as a primary complication following retroperitoneal laparoscopic radical resection of renal pelvis carcinoma or nephron-sparing surgery: A report of three cases and review of the literature

  2016cites this paper
• Limited use of surveillance imaging following nephrectomy for renal cell carcinoma.

  2016cites this paper
• Follow-up After Treatment for Renal Cell Carcinoma: The Evidence Beyond the Guidelines.

  2016influential citation
• Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients

  2016influential citation
• Oncological control associated with surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma

  2016cites this paper
• The safety and efficacy of nivolumab for the treatment of advanced renal cell carcinoma

  2016cites this paper
• The Usefulness of Chest X-Rays for T1a Renal Cell Carcinoma Surveillance.

  2016cites this paper
• Re: False-Positive Tumor Enhancement after Cryoablation of Renal Cell Carcinoma: A Prospective Study.

  2016cites this paper
• Re: Guideline of Guidelines: Follow-up after Nephrectomy for Renal Cell Carcinoma.

  2016cites this paper
• Guideline of guidelines: follow‐up after nephrectomy for renal cell carcinoma

  2016cites this paper
• Low yield of surveillance imaging after surgery for T1 kidney cancer

  2016cites this paper
• Two cases of endobronchial aspergilloma complicated with primary and metastatic lung cancer: A case report and literature review.

  2016cites this paper
• A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use

  2016cites this paper
• Patterns of surveillance imaging after nephrectomy in the Medicare population

  2016cites this paper
• Re: Oncologic Surveillance after Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach.

  2016cites this paper
• Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy.

  2016cites this paper
• Post Partial Nephrectomy Surveillance Imaging: an Evidence-Based Approach

  2015cites this paper
• The blind spots in follow-up after nephrectomy or nephron-sparing surgery for localized renal cell carcinoma

  2015cites this paper
• Postoperative surveillance imaging for patients undergoing nephrectomy for renal cell carcinoma.

  2015cites this paper
• Low incidence of port-site metastasis after robotic assisted surgery for endometrial cancer staging: descriptive analysis

  2015cites this paper
• Oncologic Surveillance After Surgical Resection for Renal Cell Carcinoma: A Novel Risk-Based Approach.

  2015cites this paper
• Re: Evaluation of the National Comprehensive Cancer Network and American Urological Association Renal Cell Carcinoma Surveillance Guidelines.

  2015cites this paper
• De blinde vlekken in de follow-up na (partiële) nefrectomie voor niercelcarcinoom

  2015cites this paper
• Clinical outcomes following laparoscopic management of pT3 renal masses: A large, multi-institutional cohort.

  2015cites this paper
• Genitourinary Cancer Survivorship Management

  2015cites this paper
• Analysis of lymph node dissection in patients with ≥7-cm renal tumors

  2014influential citation
• Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines.

  2014cites this paper
• ACR appropriateness criteria post-treatment follow-up of renal cell carcinoma.

  2014cites this paper
• Isolated loco-regional recurrence after radical nephrectomy for renal cell carcinoma: a study of 22 patients.

  2014cites this paper
• Evaluation of long-term outcome for patients with renal cell carcinoma after surgery: analysis of cancer deaths occurring more than 10 years after initial treatment Yuki KyodaKo KobayashiMegumi HirobeTetsuya ShindoFumimasa FukutaKohei Hashimoto •

  2014cites this paper
• Long natural history and spontaneous regression: A rare outcome of metastatic renal cell carcinoma

  2014cites this paper